OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h

Gene Therapy

Volumn 14, Issue 22, 2007, Pages 1564-1572

  Treschow, A ^a   Unger, C ^a   Aints, A ^a   Felldin, U ^a   Aschan, J ^a   Dilber, M S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; GLUTAMINE; OUABAIN; OUASELECT; PROTEIN SUBUNIT; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL SELECTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG SAFETY; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC SCREENING; GENETIC SELECTION; GENETIC TRANSDUCTION; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE SUBPOPULATION; MARKER GENE; MOLECULAR BIOLOGY; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL;

ANIMALS; CELL LINE; DRUG RESISTANCE; FLOW CYTOMETRY; GENE THERAPY; GENETIC ENGINEERING; GENETIC MARKERS; GENETIC VECTORS; HELA CELLS; HUMANS; JURKAT CELLS; LYMPHOCYTES; MUTAGENESIS, SITE-DIRECTED; MUTATION; OUABAIN; RATS; RETROVIRIDAE; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSGENES;

STROPHANTHUS GRATUS;

EID: 35848938959     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3303015     Document Type: Article

References (36)

1. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
2. Sauce D, Tonnelier N, Duperrier A, Petracca B, de Carvalho Bittencourt M, Saadi M et al. Influence of ex vivo expansion and retrovirus-mediated gene transfer on- prunary T lymphocyte phenotype and functions. J Hematother Stem Cell Res 2002, 11: 929-940.
3. Ferrand C, Robinet E, Contassot E, Certoux JM, Lim A, Herve P et al. Retrovirus-mediated gene transfer in primary T lymphocytes: Influence the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther 2000; 11: 1151-1164.
4. Weijtens M, van Spronsen A, Hagenbeek A, Braakman E, Martens A. Reduced graft-versus-host 4iseape-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Hum Gene Ther 2002; 13 10-198.
5. Contassot E. Murphy W, Angonin R, Pavy JJ, Bittencourt MC, Robinet E et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation 1998; 165: 1365-1370.
6. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L et al. HSV TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-luekemia. Science 1997; 276; 1719-1724.
7. Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Traversari C et al. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and unproved new vectors. Hum Gene Ther 1998; 9: 2243-2251.
8. Sauce D, Bodinier M, Garin M, Petracca B, Tonnelier N, Duperrier A et al. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 2002; 99: 1165-1173.
9. Sorrentino PP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.
10. Machiels JP, Govaerts AS, Guillaume T, Bayat B, Feyens AM, Lenoir E et al. Retrovirus-mediated gene transfer of the human multidrug resistance-associated protein into hematopoietic cells protects mice from chemotherapy-induced leukopenia. Hum Gene Ther 1999; 10 801-811.
11. Eliopoulos N, Al-Khaldi A, Beausejour CM, Momparler RL, Momparler, LF, Galipeau J. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone, marrow stromal cells. Gene Therapy 2002; 9: 452-462.
12. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, Casorati G et al. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 1994; 83: 1988-1997.
13. Deola S, Scaramuzza S, Birolo RS, Carballido-Perrig N, Ficara F, Mocchetti C et al. Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice. Hum Gene Ther 2004, 15: 305-311.
14. Hedfors IA, Beckstrom KJ, Benati C, Bonini C, Brinchmann JE. Retrovirus mediated gene transduction of human T-cell subsets. Cancer Immunol Immunother 2005; 54: 759-768.
15. Fehse B, Richters A, Putimtseva-Scharf K, Klump H, Li Z, Ostertag W et al. CD34 splice variant: An attractive marker for section of gene-modified cells. Mol Ther 2000; 1 (5 Part 1): 448-456.
16. Lemoine FM, Mesel-Lemoine M, Cherai M. Gallot G, Vie H, Leclercq V et al. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line. J Gene Med 2004; 6: 374-386.
17. Introna M, Barbui AM, Bambacioni F, Casati C, Gaipa G, Borleri G et al. Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies. Hum Gene Ther 2000; 11: 611-620.
18. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003; 101: 2099-2114.
19. Robinet E, Felise B, Ebeling S, Sauce D, Ferrand C, Tiberghien P. Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function. Cytotherapy 2005; 7: 150-157.
20. Smith, TW. The basic mechanism of inotropic action of digitalis glycosides. J Pharmacol 1984; 15 (Suppl 1): 35-51.
21. McDonough AA, Velotta JB, Srhwinger RH, Philipson KD, Earley RA. The cardiac sodium pump: Structure and function. Basic Res Cardiol 2002; 97 (Suppl 1): 119-124.
22. Aints A, Belusa R, Andersson RM, Guven H, Dilber MS. Enhanced ouabain resistance gene as a eukaryotic selection marker. Hum Gene Ther 2002; 13: 969-977.
23. Belusa R, Aizman O, Andersson W, Aperia A. Changes in Na(+)-K(+)-ATPase activity influence cell attachment to fibronectin. Am J Physiol Cell Physiol 2002; 282: C302-C309.
24. Geering K. The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr 2001; 33: 425-438.
25. Jaurán P, Horisberger JD, Richter Y, Good PJ, Rossier BC, Geering K. Processing, intracellular transport, and functional expression of endogenous and exogenous alpha-beta 3 Na,K-ATPase complexes in Xenopus oocytes. J Biol Chem 1992; 267: 577-585.
26. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 1002; 296 550-553.
27. Arteaga HJ, Hinkula. J, van Dijk-Hard I, Dilber MS, Wahren B, Christensson B et al. Choosing CCR5 or Rev siRNA in HIV-1. Nat Biotechnol 2003; 21: 230-231.
28. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126-129.
29. Ciceri F, Bonini C, Marktel S, Zappone E, Servida P, Bernardi M et al. Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation. Blood 2007; 109: 4698-4707.
30. Xiao AY, Wei L, Xia S, Rothman S, Yu SP. Ionic mechanism of quabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 2002; 22: 13504362.
31. Introna M, Rambaldi A. Suicide gene therapy and the control of graft-vs-host disease. Best Pract Res Clin Haematol 2004; 17 453-463.
32. Fehse B, Kustikova OS, Li Z, Wahlers A, Bohn W, Beyer WR et al., A novel 'sort-suicide' fusion gene vector for T cell manipulation. Gene Therapy 2002; 9: 1633-1638.
33. Carlens S, Gilljam M, Remberger M, Aschan J, Christensson B, Dilber MS. Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution. Exp Hematol 2000; 28 1137-1146.
34. Hildinger M, Eckert HG, Schilz AJ, John J, Ostertag W, Baum C. FMEV vectors: Both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Therapy 1998; 5: 1575-1579.
35. Movassagh M, Boyer O, Burland MC, Leclercq V, Klatzmann D, Lemoine FM. Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum Gene Ther 2000; 11: 1189-1200,
36. Chu YW, Wang R, Schmid I, Sakamoto KM. Analysis with flow cytometry of green fluorescent protein expression in leukemic cells. Cytometry 1999; 36: 333-339.